HLAE0101cl.2A
CEBe012-A-1
General
Cell Line |
|
| hPSCreg name | CEBe012-A-1 |
| Cite as: | CEBe012-A-1 |
| Alternative name(s) |
HLAE0101cl.2A
|
| Cell line type | Human embryonic stem cell (hESC) |
| Similar lines |
CEBe012-A (SA121) |
| Last update | 12th February 2024 |
| User feedback | |
Provider |
|
| Generator |
Novo Nordisk A/S (NOVO)
Contact:
Novo Nordisk A/S (NOVO) |
| Owner | Novo Nordisk A/S (NOVO) |
External Databases |
|
| BioSamples | SAMEA115287329 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
No |
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | male |
Phenotype and Disease related information (Donor) |
|
| Diseases | |
External Databases (Donor) |
|
| BioSamples | SAMEA6407438 |
Ethics
Also have a look at the ethics information for the parental line
CEBe012-A
.
hESC Derivation
|
The source cell information can be found in the parental cell line
CEBe012-A.
|
Culture Conditions
Characterisation
No characterisation data could be found for this subclone. Please open parental cell line CEBe012-A .Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Unknown
|
Other Genotyping (Cell Line) |
|
Genetic Modification
| Genetic modifications not related to a disease |
|
Login to share your feedback, experiences or results with the research community.